Procter & Gamble Health Limited (BOM:500126)
India · Delayed Price · Currency is INR 6,781.40
+57.80 (0.86%)
At close: Jul 27, 2026
Procter & Gamble Health Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | 3,269 | 3,125 | 2,010 | 2,295 | 1,925 |
Depreciation & Amortization | 235.9 | 217.2 | 270.1 | 279.7 | 270.1 |
Other Amortization | - | 5.33 | 3.9 | 1.3 | 0.7 |
Loss (Gain) From Sale of Assets | 18.7 | 1.73 | 5.1 | -7.1 | 5.4 |
Asset Writedown & Restructuring Costs | - | - | 201.9 | -7.3 | 7.3 |
Stock-Based Compensation | 18.8 | 10.67 | 6.9 | 5.6 | 34.1 |
Provision & Write-off of Bad Debts | -36.8 | 7.87 | 7.4 | 21.5 | 16.6 |
Other Operating Activities | 106.2 | -134.93 | -101 | 71.8 | -91.2 |
Change in Accounts Receivable | -148.1 | -804.13 | 291.7 | -329.2 | -251.5 |
Change in Inventory | -302.5 | -31.6 | 231.3 | -323.9 | -20.2 |
Change in Accounts Payable | 195.5 | 92.4 | -716.1 | 639.2 | -65 |
Change in Other Net Operating Assets | 21.1 | -240.8 | 71.9 | -286.3 | -136.3 |
Operating Cash Flow | 3,378 | 2,249 | 2,283 | 2,360 | 1,695 |
Operating Cash Flow Growth | 50.18% | -1.48% | -3.27% | 39.22% | -31.44% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Capital Expenditures | -155.1 | -114.13 | -217.3 | -424.8 | -379.2 |
Sale of Property, Plant & Equipment | 11.8 | 105.33 | 1.4 | 47.4 | 3.7 |
Other Investing Activities | 155.9 | 136.67 | 147.2 | 162.4 | 120.1 |
Investing Cash Flow | 12.6 | 127.87 | -68.7 | -215 | -255.4 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Long-Term Debt Repaid | -36.4 | - | -31.2 | -46.8 | -47.8 |
Total Debt Repaid | -36.4 | -31.2 | -31.2 | -46.8 | -47.8 |
Net Debt Issued (Repaid) | -36.4 | -31.2 | -31.2 | -46.8 | -47.8 |
Common Dividends Paid | -3,403 | -3,099 | -1,756 | -937.9 | -2,839 |
Financing Cash Flow | -3,439 | -3,130 | -4,181 | -984.7 | -2,886 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Miscellaneous Cash Flow Adjustments | - | - | - | -0.1 | 0.1 |
Net Cash Flow | -48.7 | -752.8 | -1,967 | 1,160 | -1,446 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 3,223 | 2,135 | 2,066 | 1,935 | 1,316 |
Free Cash Flow Growth | 50.95% | 3.36% | 6.74% | 47.05% | -32.40% |
Free Cash Flow Margin | 22.89% | 17.53% | 17.94% | 15.74% | 11.81% |
Free Cash Flow Per Share | 194.15 | 128.63 | 124.44 | 116.58 | 79.28 |
Levered Free Cash Flow | 2,925 | - | 1,728 | 1,716 | 1,188 |
Unlevered Free Cash Flow | 2,928 | - | 1,732 | 1,721 | 1,191 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Income Tax Paid | 1,039 | 1,084 | 851.9 | 896.6 | 638.6 |
Change in Working Capital | -234 | -984.13 | -121.2 | -300.2 | -473 |